易方达中证港股通医药卫生综合ETF(513200)财务指标
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 本期已实现收益 |
261,121,661.91 |
-85,712,433.90 |
-52,139,203.47 |
-44,307,542.68 |
| 本期利润 |
1,031,490,456.23 |
-239,035,362.61 |
-373,903,135.82 |
-213,755,793.76 |
| 加权平均基金份额本期利润 |
0.29 |
-0.10 |
-0.20 |
-0.25 |
| 本期加权平均净值利润率(%) |
35.72 |
-15.56 |
-30.97 |
-28.73 |
| 本期基金份额净值增长率(%) |
46.20 |
-15.50 |
-26.29 |
-22.40 |
| 期末可供分配利润 |
-87,475,081.23 |
-1,204,142,651.19 |
-983,435,718.88 |
-338,157,557.38 |
| 期末可供分配基金份额利润 |
-0.04 |
-0.33 |
-0.41 |
-0.20 |
| 期末基金资产净值 |
2,267,553,124.37 |
2,479,139,420.81 |
1,398,846,353.12 |
1,324,124,514.62 |
| 期末基金份额净值 |
0.98 |
0.67 |
0.59 |
0.80 |
| 基金份额累计净值增长率(%) |
-1.59 |
-32.69 |
-41.28 |
-20.34 |
微信公众号
证券之星APP
基本资料
